pros and cons of glp 1 drugs Part 2 a 3-Part Series; GLP-1 Medications for Weight Loss The GLP-1 Agonists and Obesity:

Description

[DOI] [PubMed] [Google Scholar] 73.Armstrong M.J., Houlihan D.D., Rowe I.A., Clausen W.H., Elbrnd B., Gough S.C., Tomlinson J.W., Newsome P.N

Tirzepatide offers a more holistic approach

Alcohol was then reintroduced for 2 weeks, and alcohol intake was recorded while the assigned GLP1 receptor agonist treatment was continued

However, these potential savings must be carefully weighed against the short-term financial burden

Lancet (London, England) 394(10193):121130 Gerstein HC, Lee S-F, Par G, Bethel MA, Colhoun HM, Hoover A, Lakshmanan M, Lin Y, Pirro V, Qian H-R et al (2023) Biomarker changes associated with both dulaglutide and cardiovascular events in the REWIND randomized controlled trial: a nested case-control post hoc analysis